7Baggers
 Inmune Bio, Inc. Announces Key Developments in Clinical Programs  TradingView Mon, 10 Nov 2025 22:15:00 GMT
 btig maintains inmune bio(inmb.us) with hold rating  富途牛牛 Mon, 03 Nov 2025 17:31:00 GMT
 published on: 2025-11-02 21:20:18  newser.com Mon, 03 Nov 2025 02:20:18 GMT
 published on: 2025-11-02 20:37:16  newser.com Mon, 03 Nov 2025 01:37:16 GMT
 INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript  Insider Monkey Sat, 01 Nov 2025 12:19:27 GMT
 inmune bio’s earnings call highlights progress and challenges  TipRanks Sat, 01 Nov 2025 00:42:06 GMT
 INmune Bio Shrinks Losses While Analysts See Upside Ahead  Finimize Fri, 31 Oct 2025 17:06:40 GMT
 earnings call transcript: inmune bio beats q3 2025 eps forecast, stock dips  Investing.com Nigeria Fri, 31 Oct 2025 07:31:39 GMT
 Inmune Bio’s Earnings Call Highlights Progress and Challenges  TipRanks Fri, 31 Oct 2025 07:00:00 GMT
 inmune bio reports q3 2025 financial results  TipRanks Fri, 31 Oct 2025 05:49:22 GMT
 transcript : inmune bio, inc., q3 2025 earnings call, oct 30, 2025  MarketScreener Fri, 31 Oct 2025 03:05:26 GMT
 inmb maintains strong cash position with $27.7 million on hand  GuruFocus Thu, 30 Oct 2025 22:32:52 GMT
 published on: 2025-10-30 05:45:10  newser.com Thu, 30 Oct 2025 10:45:10 GMT
 inmune bio reports q3 2025 financial results  TipRanks Thu, 30 Oct 2025 07:00:00 GMT
 inmune bio to host q3 results conference call  TipRanks Thu, 30 Oct 2025 07:00:00 GMT
 Inmune Bio to Host Q3 Results Conference Call  TipRanks Tue, 28 Oct 2025 07:00:00 GMT

INmune Bio, Inc
(NASDAQ:INMB) 

INMB stock logo

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid t...

Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends